ANAB
Income statement / Annual
Last year (2023), AnaptysBio, Inc.'s total revenue was $17.16 M,
an increase of 66.78% from the previous year.
In 2023, AnaptysBio, Inc.'s net income was -$163.62 M.
See AnaptysBio, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$17.16 M
|
$10.29 M
|
$63.18 M
|
$75.00 M
|
$8.00 M
|
$5.00 M
|
$10.00 M
|
$16.68 M
|
$17.57 M
|
$15.84 M
|
| Cost of Revenue |
$2.38 M |
$2.34 M |
$98.50 M |
$80.03 M |
$99.34 M |
$56.20 M |
$29.44 M |
$15.42 M |
$17.30 M |
$8.61 M |
| Gross Profit |
$14.78 M |
$7.95 M |
-$35.32 M |
-$5.03 M |
-$91.34 M |
-$51.20 M |
-$19.44 M |
$1.27 M |
$267,000.00 |
$7.22 M |
| Gross Profit Ratio |
0.86 |
0.77 |
-0.56 |
-0.07 |
-11.42 |
-10.24 |
-1.94 |
0.08 |
0.02 |
0.46 |
| Research and Development
Expenses |
$132.28 M
|
$88.80 M
|
$98.50 M
|
$80.03 M
|
$99.34 M
|
$56.20 M
|
$29.44 M
|
$15.42 M
|
$17.30 M
|
$8.61 M
|
| General & Administrative
Expenses |
$41.95 M
|
$36.64 M
|
$21.49 M
|
$18.85 M
|
$16.09 M
|
$15.53 M
|
$9.34 M
|
$4.29 M
|
$3.59 M
|
$2.35 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$41.95 M
|
$36.64 M
|
$21.49 M
|
$18.85 M
|
$16.09 M
|
$15.53 M
|
$9.34 M
|
$4.29 M
|
$3.59 M
|
$2.35 M
|
| Other Expenses |
-$2,000.00 |
$12,000.00 |
$37,000.00 |
-$11,000.00 |
$1,000.00 |
-$159,000.00 |
$229,000.00 |
-$20,000.00 |
-$207,000.00 |
$2,000.00 |
| Operating Expenses |
$174.23 M |
$125.44 M |
$119.99 M |
$98.88 M |
$115.43 M |
$71.72 M |
$38.78 M |
$19.71 M |
$20.89 M |
$10.97 M |
| Cost And Expenses |
$174.23 M |
$125.44 M |
$119.99 M |
$98.88 M |
$115.43 M |
$71.72 M |
$38.78 M |
$19.71 M |
$20.89 M |
$10.97 M |
| Interest Income |
$18.87 M |
$7.55 M |
$431,000.00 |
$3.96 M |
$10.98 M |
$6.69 M |
$1.62 M |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$18.08 M |
$21.11 M |
$1.45 M |
$0.00 |
$1.04 M |
$1.65 M |
$1.78 M |
$458,000.00 |
$460,000.00 |
$1.28 M |
| Depreciation &
Amortization |
$2.38 M
|
$2.34 M
|
$2.09 M
|
$559,000.00
|
$514,000.00
|
$315,000.00
|
$183,000.00
|
$233,000.00
|
$274,000.00
|
$308,000.00
|
| EBITDA |
-$135.83 M
|
-$107.59 M
|
-$56.35 M
|
-$19.37 M
|
-$96.45 M
|
-$60.20 M
|
-$26.93 M
|
-$3.05 M
|
-$3.26 M
|
$5.18 M
|
| EBITDA Ratio |
-7.92 |
-10.46 |
-0.89 |
-0.26 |
-12.06 |
-12.04 |
-2.69 |
-0.18 |
-0.19 |
0.33 |
| Operating Income Ratio
|
-9.58
|
-11.19
|
-0.9
|
-0.32
|
-13.43
|
-13.34
|
-2.88
|
-0.18
|
-0.19
|
0.31
|
| Total Other
Income/Expenses Net |
-$7.34 M
|
-$13.55 M
|
-$982,000.00
|
$3.95 M
|
$9.94 M
|
-$159,000.00
|
-$1.14 M
|
-$776,000.00
|
-$1.48 M
|
-$57,000.00
|
| Income Before Tax |
-$163.62 M |
-$128.70 M |
-$57.80 M |
-$19.93 M |
-$97.49 M |
-$61.85 M |
-$30.07 M |
-$4.26 M |
-$5.27 M |
$3.53 M |
| Income Before Tax Ratio
|
-9.54
|
-12.51
|
-0.91
|
-0.27
|
-12.19
|
-12.37
|
-3.01
|
-0.26
|
-0.3
|
0.22
|
| Income Tax Expense |
-$4,000.00 |
$24,000.00 |
-$603,000.00 |
-$11,000.00 |
-$152,000.00 |
-$192,000.00 |
$1.82 M |
$205,000.00 |
$139,000.00 |
$1.28 M |
| Net Income |
-$163.62 M |
-$128.72 M |
-$57.19 M |
-$19.92 M |
-$97.34 M |
-$61.66 M |
-$30.07 M |
-$4.26 M |
-$5.41 M |
$3.53 M |
| Net Income Ratio |
-9.54 |
-12.51 |
-0.91 |
-0.27 |
-12.17 |
-12.33 |
-3.01 |
-0.26 |
-0.31 |
0.22 |
| EPS |
-6.08 |
-4.57 |
-2.08 |
-0.73 |
-3.6 |
-2.5 |
-1.52 |
-0.23 |
-0.38 |
0.0164 |
| EPS Diluted |
-6.08 |
-4.57 |
-2.08 |
-0.73 |
-3.6 |
-2.5 |
-1.52 |
-0.23 |
-0.36 |
0.0155 |
| Weighted Average Shares
Out |
$26.92 M
|
$28.17 M
|
$27.43 M
|
$27.30 M
|
$27.06 M
|
$24.67 M
|
$19.78 M
|
$18.16 M
|
$14.15 M
|
$14.15 M
|
| Weighted Average Shares
Out Diluted |
$26.92 M
|
$28.17 M
|
$27.43 M
|
$27.30 M
|
$27.06 M
|
$24.67 M
|
$19.78 M
|
$18.16 M
|
$14.99 M
|
$14.99 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
